WO1988005337A1 - Process for preparation of monodispersed barium containing ferrites - Google Patents

Process for preparation of monodispersed barium containing ferrites Download PDF

Info

Publication number
WO1988005337A1
WO1988005337A1 PCT/US1988/000083 US8800083W WO8805337A1 WO 1988005337 A1 WO1988005337 A1 WO 1988005337A1 US 8800083 W US8800083 W US 8800083W WO 8805337 A1 WO8805337 A1 WO 8805337A1
Authority
WO
WIPO (PCT)
Prior art keywords
barium
particles
ferrite
dispersion
colloidal
Prior art date
Application number
PCT/US1988/000083
Other languages
French (fr)
Inventor
Egon Matijevic
Original Assignee
Clarkson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clarkson University filed Critical Clarkson University
Publication of WO1988005337A1 publication Critical patent/WO1988005337A1/en
Priority to NO884064A priority Critical patent/NO884064L/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B03SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03CMAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C1/00Magnetic separation
    • B03C1/005Pretreatment specially adapted for magnetic separation
    • B03C1/01Pretreatment specially adapted for magnetic separation by addition of magnetic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G49/00Compounds of iron
    • C01G49/0018Mixed oxides or hydroxides
    • C01G49/0036Mixed oxides or hydroxides containing one alkaline earth metal, magnesium or lead
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/01Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics
    • C04B35/26Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics based on ferrites
    • C04B35/2683Other ferrites containing alkaline earth metals or lead
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01FMAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/44Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of magnetic liquids, e.g. ferrofluids
    • H01F1/445Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of magnetic liquids, e.g. ferrofluids the magnetic component being a compound, e.g. Fe3O4
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/30Particle morphology extending in three dimensions
    • C01P2004/38Particle morphology extending in three dimensions cube-like
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/51Particles with a specific particle size distribution
    • C01P2004/52Particles with a specific particle size distribution highly monodisperse size distribution
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/60Particles characterised by their size
    • C01P2004/62Submicrometer sized, i.e. from 0.1-1 micrometer
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/42Magnetic properties
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/60Optical properties, e.g. expressed in CIELAB-values

Definitions

  • This invention relates to a process and to the composition of matter resulting from this process. More specifically, this invention is directed to a process for the preparation of a colloidal dispersion of ferrite particles containing barium.
  • the particles produced by this process have a very narrow particle size distribution and are superparamagnetic in their response to a magnetic field. These particles are useful in magnetic recording media; in separation of various constituents of complex fluids (i.e. blood, cerebrospinal fluid or urine); and in certain diagnostic applications.
  • the precursors to the formation of the solid phase are, in most instances, one or more solute complexes.
  • This procedure is, thus, based upon the control of kinetics of the complexation reaction in order to achieve a single burst of nuclei, which are then allowed to grow uniformly, resulting in particles of narrow size distribution.
  • the constituent solutes are generated at the proper rate, their even distribution onto existing nuclei results in the least increase in total free energy of the dispersion, thus, controlling the growth of such particles by proper control of particle charge. Control of the charge on such particles is traditionally achieved by adjustment in pH or through the introduction of additives. In the absence of such control of charge, aggregation of such particles will result.
  • a precipitate is initially prepared.
  • the form of precipitate is generally other than in the desired colloidal form.
  • This precipitate is then subsequently changed, through crystallization, recrystallization or dissolution/ reprecipitation into the desired form of dispersed matter.
  • a most common example of this procedure is sol-gel transformation.
  • the mechanisms involved in these transformations are not generally well understood and, thus, the results are not readily predictable. It is also difficult to recognize if a phase transformation has in fact occurred since the initial state (form) of the dispersed matter may be either so short lived or so finely dispersed, the transition from one state to another is difficult to detect.
  • the literature does describe the preparation of spherical magnetite particles by phase transformation techniques.
  • colloidal particles Because of the nature of the colloidal particles, and the various methods used in their preparation, their physical properties are often unpredictable. For example, in the preparation of colloidal magnetite and ferrites, their • respective crystal structure can often vary and so to the response of such materials to magnetic fields.
  • the production of barium ferrite powders has traditionally involved the phase transformation of large particles of barium ferrite at elevated temperature, see for example Haneda, K, et al., J. Am. Cer. Soc. (1974) 57, 354. During production, the ferrite is milled and calcined at elevated temperatures to reduce particle size from multidomain to single-domain.
  • the above and related objects are achieved by providing a process for the preparation of well-defined monodispersed particles of barium containing ferrites.
  • This process involves the phase transformation of ferrous hydroxide gel, in a nonoxidizing atmosphere.
  • This gel is then contacted with barium nitrate solution.
  • the nitrate salt acts as a mild oxidizing agent, thus, promoting the phase transformation of the gel to barium containing ferrite particles.
  • barium is incorporated within the crystal lattice of the ferrite particle.
  • the resultant crystalline materials have a narrow particle size distribution, and a cubic morphology.
  • These crystalline particles are unique among ferrites in that they are readily dispersible in an aqueous medium and are superparamagnetic in response to magnetic fields.
  • the introduction of barium ions into the ferrite crystalline lattice is believed to attenuate the magnetic properties of these materials, thus, accounting for reduced particle/particle interactions (aggregation). This attenuation of magnetic properties of the ferrite can be controlled within limits, depending upon the relative concentration of barium ions introduced into these crystalline materials.
  • These modified ferrite particles have surface characteristics which are favorable for the adsorption of protein (i.e. cellular materials), and yet maintain the stability of the dispersion in aqueous fluids.
  • the adsorbed protein or cell can, thus, be separated along with the barium ferrite particle without alteration or destruction of the native physical and/or physiological characteristics of the adsorbed material.
  • the barium ferrite particle/protein complex can be redispersed in fluid media and subjected to quantitative or qualitative analysis.
  • the complex can be treated to effect dissociation of the adsorbed materials from the barium ferrite particles, and the particles thereupon separated from the fluid and recycled.
  • Fig. 1 is a reproduction of a photomicrograph depicting the monodispersed barium containing ferrite particles of this invention.
  • This invention provides a reproducible process for the synthesis of colloidal particles of narrow particle size distribution from barium salts and a ferrous hydroxide gel.
  • Colloidal particles are prepared from the above materials by phase transformation, in an inert atmosphere, of gelatinous ferrous hydroxide, in the presence of barium salts. This phase transformation is conducted under mild oxidizing conditions and in an aqueous environment.
  • This process initially involves the formation of ferrous hydroxide from a ferrous salt (i.e. ferrous chloride) and a stock solution of potassium hydroxide and potassium nitrate.
  • ferrous salt i.e. ferrous chloride
  • stock solution i.e. potassium hydroxide and potassium nitrate.
  • ferrous hydroxide gel suspension which is stable at a slightly acidic pH (approximately 6.4).
  • barium salts i.e. barium nitrate
  • the phase transformation of the gel to crystalline ferrite particles is initiated.
  • this gelatinous precipitate undergoes a phase transformation to produce ferrite particles containing barium with cubic crystal lattice.
  • the mildly acidic conditions affect the rate and degree of oxidation of the hydroxide gel to the corresponding crystalline ferrites.
  • the conditions prevailing during the initial formation of the hydroxide, and its subsequent phase transformation, are critical to the process of this invention in order to avoid the formation of hematite.
  • the gelatinous precipitate Once the gelatinous precipitate is formed, it is aged at elevated temperatures (approximately 90°C) to effect the phase transformation to the desired tolerance.
  • the magnetic particles which are ultimately recovered from the reaction mass are readily identifiable, easily redispersible in aqueous media, and have superparamagnetic properties in response to the magnetic field.
  • Ferrous hydroxide (Fe(OH)2) is initially formed by combining aqueous solutions of the ferrous salt with an aqueous solution containing a source of hydroxide ions. The quantity of ferrous salt solution combined with the alkali is carefully adjusted to produce a ferrous hydroxide solution of slightly acidic (pH approximately 6.4) character.
  • ferrous hydroxide solution is prepared, it is contacted with an aqueous solution of a suitable barium salt (i.e. Ba(N03)2).
  • a suitable barium salt i.e. Ba(N03)2.
  • the two solutions are combined in an inert atmosphere (e.g. argon or nitrogen) and permitted to interact at ambient (room) temperature. After about 30 minutes, the interaction of the barium salt solution and the ferrous hydroxide results in the incorporation of finite amounts of Ba ⁇ + ions within the ferrous hydroxide gel (presumably by ion exchange).
  • This suspension can thereafter be transferred to one or more sealed containers and aged at elevated temperatures until the phase transformation of the gel to the solid particles has been completed.
  • the solid particles are removed from the sealed containers, and washed by resuspension in water.
  • the magnetic properties of the colloidal particles permit their ready separation from other non-magnetic particles contained in the suspension. This separation is achieved by simply placing a magnet in contact with the side or bottom of the vessel containing the suspension, allowing the magnetic particles to collect on the interior of the vessel corresponding to the placement of the magnet and decanting the wash fluid containing the non-magnetic particles. This washing/decanting process can be repeated until essentially all non-magnetic particles and other water soluble materials are removed. The particles can thereafter be air dried or calcined. The particles obtained through this process in the foregoing manner are illustrated in Fig. 1.
  • These particles are uniform and of a relatively narrow size distribution.
  • the particle shape can vary from cuboidal to hexagonal, whereas relative size remains essentially uniform.
  • these particles are submicron in size and most preferably in the range of from 0.1 to 0.8 micrometers. As noted above, these particles, can be calcined in the conventional manner to modify one or more of their physical properties.
  • barium modified ferrite particles are, thus, capable of formation of stable colloidal dispersions in fluid media.
  • the surface characteristics of the particles of these colloidal dispersions have a natural affinity for adsorption of protein (i.e. cells, ligands, steroids, hormones, etc.). This adsorption is accomplished while maintaining the stability of the particle dispersion in the fluid medium.
  • the adsorption characteristics of the barium modified ferrites is essentially surface charge dependent.
  • the characteristic surface charge of these particles can be readily modified by adjustment in pH.
  • the variation in surface charge follows a characteristic signoid curve. At a pH above the particles isolectric point, the surface charge on these particles is positive; and at a pH below the isolectric point, the surface charge on these particles is negative.
  • these particles can rapidly and efficiently adsorb proteinaceous materials without adverse or destructive effect upon their physical and/or physiological properties.
  • This ability to effectively adsorb protein and its separation upon application of a magnetic field is unique to the barium modified colloidal particles of this invention.
  • the effective adsorption of protein without disruptive effect upon the other constituents of the fluid dispersion is of critical importance not only to preservation of the adsorbed species, but also to the particulates and dissolved matter which remain within the fluid.
  • This latter application involves the use of the colloidal particles as scavengers to remove undesirable components of a fluid sample (presumably interferents) prior to analysis of the residual material which remains in suspension.
  • the particles thus, have application in both industrial and biological environments, involving magnetic separation techniques of the type described in the following U.S. Patents: 4,001,288; 4,247,406; 4,018,886; 4,285,819; 4,147,767; 4,335,094; 4,152,210; 4,452,773; 4,169,804; 4,454,234; and 4,230,685 - all of which are hereby incorporated by reference in their entirety.
  • the barium modified ferrites of this invention thus provide, for the first time, a practical and efficacious material which can perform reliably in such separation systems and yet are compatible with relatively simple, straightforward methodologies.
  • the superparamagnetic colloidal barium ferrite particles obtained by this process can be used directly or modified by treatment with a binding material (i.e. antigen, antibody, binding protein, complement DNA), in accordance with conventional techniques described in the open literature.
  • a binding material i.e. antigen, antibody, binding protein, complement DNA
  • This treatment (coating) with these binding materials is performed under conditions which retain the desirable attributes of the barium ferrite particles.
  • These untreated or treated particles can thereafter be combined with an industrial or biological fluid having one or more constituents capable of binding to the particles. After a suitable incubation period, the particles, and presumably the constituents of the fluid for which they are 13
  • the barium ferrites prepared in this manner are also suitable in other industrial and biological applications, including the use as recording media, as delivery systems for therapeutics (ceramic composition and the like).
  • a reactive solution is initially prepared from appropriate volumes of 5 mol dm _ 3 KOH and 2 mol dm _ 3 KNO3 stock solutions.
  • the individual components of this reactive solution were combined in a two-necked round bottom flask, equipped with a gas -outlet and a gas-inlet.
  • Argon was bubbled for 2 hours through a solution of desired concentrations of KOH and KNO3 in oxygen free distilled water.
  • a calculated amount of a 1 mol dm"3 F Cl2 stock solution was added and bubbling of argon continued for 30 minutes. During this 30 minute period a dark green gelatinous precipitate is formed.
  • the solid reaction products obtained in the foregoing manner consisted predominantly of a mixture of particles, the main fraction of which was magnetic. To separate the latter, the precipitate was first agitated in an ultrasonic bath, then the magnetic particles were retained at the bottom of the test tube with the aid of a magnet, while the remaining suspension of nonmagnetic particles was decanted. The magnetic portion was resuspended again in doubly distilled water and the washing/decanting procedure repeated several times.
  • Magnetic properties were determined with a vibrating magnetometer on the original barium ferrite powders and on the annealed solids.
  • the coercivity before annealing ranged between 60 and 100 Oe and the saturation magnetization varied between 60 and 80 emu/g, while the squareness was between 0.12 and 0.18, depending on the sample.
  • the particles thus obtained could be physically modified by conventional treatment regimes.
  • the calcination was carried out at temperatures ranging between 300 and 900° C for 2-12 hours in air or in an air inert atmosphere (argon). This treatment brought about some rounding of the crystal edges.
  • the dried powders obtained by the foregoing procedures were readily redispersible in aqueous solutions. Their particle size ranged from between 0.1 and 0.8 mm (cubic edge) and the size could be altered by varying the concentrations of the solutions used in this synthesis (as illustrated in Tables I & II). As illustrated in these Tables, the chemical composition of the particles also varied with experimental conditions. Thus, the content of the barium within the ferrite could be varied between 1 to 7% by weight. As noted previously, the substitution of Ba ⁇ + for Fe ⁇ in the ferrite crystal lattice, at concentrations in the range of from about 1 to about 7% (w/w), is effective to alter the magnetic properties of these crystalline materials and, thus, substantially reduce particle to particle interaction.
  • a monoclonal antibody (MoAb) specific for a surface marker on human red blood cells is directly adsorbed onto the colloidal barium ferrite particles of Example I.
  • the particle size of the ferrite particle selected for use in the system was approximately 1.09 micrometers.
  • Sufficient MoAb was contacted with the colloidal particles to effect essentially complete saturations of the particle surface.
  • Antibody coated barium ferrite particles were then slurried with a whole blood sample for a brief incubation period, a magnet placed in contact with the bottom of the container and magnetic particles allowed to collect upon the inside surface of the container opposite the magnet. After a relative brief interval, the fluid phase of the sample is substantially depleted of both red blood cells and magnetic particles. The fluid phase is then aspirated from the sample container into a Coulter Model S-Plus cell counter and the sample subjected to analysis. The data available from such analysis permitted the identification of two discrete sub-populations of white blood cells. The ability to effectively separate erythrocytes from a whole blood sample in the above manner, without the resort to lytic reagents, offers significant advantages in the recovery of the leukocyte population.
  • the magnetic separation which is effected in the above manner has been achieved without substantial alteration in the physiological environment of the sample.
  • the leukocytes have retained their native physical, chemical and immunochemical properties. This can be critical in further differentiation of the leukocyte sub-populations from one another and in the continued vitality of these cells.

Abstract

An improved process for preparation of well-defined monodispersed colloidal particles of barium containing ferrites. This process involves the formation of colloidal barium ferrite particles in aqueous media by phase transformation of a ferrous hydroxide gel in the presence of barium ions. In this process, a magnetite is initially formed in aqueous solution and barium substituted into the resultant particle by displacement of Fe2+. This procedure is performed in a nonoxidizing atmosphere and under mildly caustic conditions. As the reaction proceeds to completion (aging) the system becomes decidedly more acidic. The colloidal particles produced in accordance with this invention are easily dispersible in aqueous media and, unlike magnetite, are superparamagnetic in response to a magnetic field. This procedure is in sharp contrast to more traditional methods of solid state transformations of the magnetite to ferrite at temperatures typically in excess of 1000°C.

Description

Title: PROCESS FOR PREPARATION OF MONODISPERSED BARIUM CONTAINING FERRITES
BACKGROUND OF THE INVENTION
Field of the Invention - This invention relates to a process and to the composition of matter resulting from this process. More specifically, this invention is directed to a process for the preparation of a colloidal dispersion of ferrite particles containing barium. The particles produced by this process have a very narrow particle size distribution and are superparamagnetic in their response to a magnetic field. These particles are useful in magnetic recording media; in separation of various constituents of complex fluids (i.e. blood, cerebrospinal fluid or urine); and in certain diagnostic applications.
Description of the Prior Art - The preparation of colloidal particles from inorganic substances has, until very recently, been a highly empirical "science". For the most part, the efficacy of such processes was quite subjective and generally the relative success or failure thereof required laborious trial and error in order to attain adequate process definition. More specifically, the efficacy of a particular technique, even if it were reproducible to a degree, rarely produced a consistently acceptable product. The inability to achieve reproducible results from such processes has led many to regard the synthesis of inorganic colloidal particles as largely the domain of the empiricist.
With the advent of more sophisticated analytical tools (i.e. electron microscopy), the fascination with inorganic colloidal particles, and more particularly, monodispersed inorganic colloidal particles, has been rekindled. The initial interest in such materials was primarily as a scientific curiosity, however, more recent developments have found them useful as supports for catalysts, in ceramics, pigments, films, recording media, coatings, in various diagnostic and therapeutic environments, as well as a myriad of other applications.
The term "monodispersed" as used in the discussion of the prior art and throughout the balance of this disclosure is intended as referring to a population of particulate materials having a narrow particle size distribution.
A. survey of the various techniques for synthesis of monodispersed, inorganic colloidal particles has recently appeared in the technical literature, see Matijevic, E.,
"Monodispersed Colloids: Art and Science", Langmuir, Vol. 2, No. 1 , pp. 12-20 (1986).
The procedures which have been previously developed by the inventor for synthesis of inorganic colloidal dispersions of narrow particle size distribution have been described in detail in a number of papers which have appeared in the technical literature, see for example, Matijevic, E., Ann. Rev. Mater. Sci. (1985), 15, 483 & Matijevic, E., Ace. Chem. Res. (1981), 14, 22. Two of the procedures described in the above article can be conveniently grouped into the following categories: (1) precipitation from homogenous solution (i.e. forced hydrolysis, controlled release of anions and controlled release of cations); and (2) phase transformations. What is, however, to be appreciated is that each of the above procedures will have one or more shortcomings or advantages for synthesis of a specific colloidal material. Thus, the production of an acceptable product, in accordance with each of the processes from the same starting materials, is both highly unpredictable and unlikely. More specifically, in order to produce colloidal particles of specific characteristics, both of the above procedures may have to be attempted before one can be identified as potentially useful or efficacious. At that point, additional refinement will be required before an acceptable product is attainable.
In the procedures involving precipitation of inorganic compounds from homogenous solutions, the precursors to the formation of the solid phase are, in most instances, one or more solute complexes. This procedure is, thus, based upon the control of kinetics of the complexation reaction in order to achieve a single burst of nuclei, which are then allowed to grow uniformly, resulting in particles of narrow size distribution. Where the constituent solutes are generated at the proper rate, their even distribution onto existing nuclei results in the least increase in total free energy of the dispersion, thus, controlling the growth of such particles by proper control of particle charge. Control of the charge on such particles is traditionally achieved by adjustment in pH or through the introduction of additives. In the absence of such control of charge, aggregation of such particles will result.
In a phase transformation procedure, a precipitate is initially prepared. The form of precipitate is generally other than in the desired colloidal form. This precipitate is then subsequently changed, through crystallization, recrystallization or dissolution/ reprecipitation into the desired form of dispersed matter. A most common example of this procedure is sol-gel transformation. The mechanisms involved in these transformations are not generally well understood and, thus, the results are not readily predictable. It is also difficult to recognize if a phase transformation has in fact occurred since the initial state (form) of the dispersed matter may be either so short lived or so finely dispersed, the transition from one state to another is difficult to detect. The literature does describe the preparation of spherical magnetite particles by phase transformation techniques. Analogous techniques have also been used in the preparation of cobalt, nickel and cobalt/nickel ferrites, see for example Regazzoni, A. E.; Matijevic, E., Corrosion (1982), 38, 212; Tamura, H. and Matijevic, E., Colloid Interface Sci. (1982), 90,100; Regazzoni, A. E.; Matijevic, E., Colloids Surf. (1983) 6, 189.
Because of the nature of the colloidal particles, and the various methods used in their preparation, their physical properties are often unpredictable. For example, in the preparation of colloidal magnetite and ferrites, their respective crystal structure can often vary and so to the response of such materials to magnetic fields. The production of barium ferrite powders has traditionally involved the phase transformation of large particles of barium ferrite at elevated temperature, see for example Haneda, K, et al., J. Am. Cer. Soc. (1974) 57, 354. During production, the ferrite is milled and calcined at elevated temperatures to reduce particle size from multidomain to single-domain.
The majority of procedures used in the preparation of barium ferrites have involved some sort of phase transformation of these particles in the dry state, e.g. Tenzer, R.K., J. App. Phys. (1963) 34, 1267. A number of other investigators have been successful in the preparation of barium ferrites from aqueous media; however, none of these so-called "wet" procedures have resulted in particles of uniform size distribution. It has been recently demonstrated that colloidal magnetite and some ferrites, having a narrow particle size distribution, can be produced by crystallization of ferrous hydroxide gels in the presence of a mild oxidizing agent.
Because of their high anisotropic values caused by their crystal structure, hexagonal barium ferrites have found application as permanent magnetic materials, recording tapes and the like. This large anisotrophy makes its difficult to reverse this tendency of the particles in the direction of magnetization. Also because of such high anisotropic values (typically 0.3 J/cm^), the particles are single domain and very difficult to demagnetize, particularly where the particle size is kept below values (0.2 micrometers). As is thus readily appreciated, the relative strength and permanency of the magnetic forces between these particles renders them essentially unsuitable for formation of stable colloidal dispersions in fluid media.
For the above and related reasons, ferrites produced in the above manner have had rather limited application, and then only in industrial applications. Where attempts have been made to adapt such materials to the biological environments, (i.e. separation processes) the results have largely been unsatisfactory for the reasons indicated previously (i.e. instability of dispersion). Where such colloidal materials do in fact have an affinity for a cellular analyte, the relatively strong magnetic forces between the particles can be destructive of the adsorbed cells when the particles form aggregates. The unsatisfactory nature of these prior art materials is further manifest when an attempt is made at separation of the magnetic particles and the cellular analyte. Generally, such separation cannot be effected without incurring modification or destruction to the analyte physiology and integrity. Because of these and associated shortcomings, it is apparent that currently available materials would not be suitable in the separation processes involving complex fluids, notably, complex biological fluids such as blood, cerebrospinal fluid or urine. OBJECTS OF THE INVENTION
It is the principle object of this invention to remedy the above as well as related deficiencies in the prior art.
It is another object of this invention to provide a reproducible, energy efficient process for the synthesis of monodispersed barium containing ferrite particles.
It is yet another object of this invention to provide a reproducible process for the synthesis of a class of ferrites which are useful in the separation of constituents of complex fluids, notably, biological fluids.
It is still yet another object of this invention to provide a process for the synthesis of a class of ferrites whose magnetic properties can be tailored to the separation of constituents of biological fluids without altering the native characteristics or physiology of such constituents.
It is a further object of this invention to provide a process for the synthesis of a class of ferrites which are useful in separation processes and, once separated, are redispersible in aqueous media.
It is yet a further object of this invention to provide a class of ferrite material which can form a stable colloidal dispersion and is, thus, useful in a variety of separation processes, notably those involving complex biological fluids. SUMMARY OF THE INVENTION
The above and related objects are achieved by providing a process for the preparation of well-defined monodispersed particles of barium containing ferrites. This process involves the phase transformation of ferrous hydroxide gel, in a nonoxidizing atmosphere. This gel is then contacted with barium nitrate solution. The nitrate salt acts as a mild oxidizing agent, thus, promoting the phase transformation of the gel to barium containing ferrite particles. During this conversion process, barium is incorporated within the crystal lattice of the ferrite particle. The resultant crystalline materials have a narrow particle size distribution, and a cubic morphology.
These crystalline particles are unique among ferrites in that they are readily dispersible in an aqueous medium and are superparamagnetic in response to magnetic fields. The introduction of barium ions into the ferrite crystalline lattice is believed to attenuate the magnetic properties of these materials, thus, accounting for reduced particle/particle interactions (aggregation). This attenuation of magnetic properties of the ferrite can be controlled within limits, depending upon the relative concentration of barium ions introduced into these crystalline materials. These modified ferrite particles have surface characteristics which are favorable for the adsorption of protein (i.e. cellular materials), and yet maintain the stability of the dispersion in aqueous fluids. These particles exhibit superparamagnetic response in the presence of a magnetic field, thus, enable their relatively gentile aggregation within the fluid dispersion. The adsorbed protein or cell can, thus, be separated along with the barium ferrite particle without alteration or destruction of the native physical and/or physiological characteristics of the adsorbed material. After such separation from the dispersion, the barium ferrite particle/protein complex can be redispersed in fluid media and subjected to quantitative or qualitative analysis. Alternatively, the complex can be treated to effect dissociation of the adsorbed materials from the barium ferrite particles, and the particles thereupon separated from the fluid and recycled.
BRIEF DESCRIPTION OF THE DRAWING
Fig. 1 is a reproduction of a photomicrograph depicting the monodispersed barium containing ferrite particles of this invention.
DESCRIPTION OF THE INVENTION INCLUDING PREFERRED EMBODIMENTS
This invention provides a reproducible process for the synthesis of colloidal particles of narrow particle size distribution from barium salts and a ferrous hydroxide gel. Colloidal particles are prepared from the above materials by phase transformation, in an inert atmosphere, of gelatinous ferrous hydroxide, in the presence of barium salts. This phase transformation is conducted under mild oxidizing conditions and in an aqueous environment.
This process initially involves the formation of ferrous hydroxide from a ferrous salt (i.e. ferrous chloride) and a stock solution of potassium hydroxide and potassium nitrate. The combination of the ferrous salt and the stock solution results in the formation of a ferrous hydroxide gel suspension which is stable at a slightly acidic pH (approximately 6.4). When barium salts (i.e. barium nitrate) are added to the gelatinous ferrous hydroxide, the phase transformation of the gel to crystalline ferrite particles is initiated. Upon continued aging, this gelatinous precipitate undergoes a phase transformation to produce ferrite particles containing barium with cubic crystal lattice. The mildly acidic conditions affect the rate and degree of oxidation of the hydroxide gel to the corresponding crystalline ferrites.
The conditions prevailing during the initial formation of the hydroxide, and its subsequent phase transformation, are critical to the process of this invention in order to avoid the formation of hematite. Once the gelatinous precipitate is formed, it is aged at elevated temperatures (approximately 90°C) to effect the phase transformation to the desired tolerance. The magnetic particles which are ultimately recovered from the reaction mass are readily identifiable, easily redispersible in aqueous media, and have superparamagnetic properties in response to the magnetic field.
The materials which are suitable for use in this process are preferably reagent grade chemicals. Ferrous hydroxide (Fe(OH)2) is initially formed by combining aqueous solutions of the ferrous salt with an aqueous solution containing a source of hydroxide ions. The quantity of ferrous salt solution combined with the alkali is carefully adjusted to produce a ferrous hydroxide solution of slightly acidic (pH approximately 6.4) character.
Once the ferrous hydroxide solution is prepared, it is contacted with an aqueous solution of a suitable barium salt (i.e. Ba(N03)2).
The two solutions are combined in an inert atmosphere (e.g. argon or nitrogen) and permitted to interact at ambient (room) temperature. After about 30 minutes, the interaction of the barium salt solution and the ferrous hydroxide results in the incorporation of finite amounts of Ba^+ ions within the ferrous hydroxide gel (presumably by ion exchange). This suspension can thereafter be transferred to one or more sealed containers and aged at elevated temperatures until the phase transformation of the gel to the solid particles has been completed.
In the preferred embodiments of this invention, the following ranges of concentrations of materials and process conditions have produced ferrites containing barium consistent with the objectives of this invention:
FeCl2: 0.05 - 0.20 mol dm"3 KOH: 0.05 - 0.20 mol dm"3 B a(N03)2: 0.05 - 0.50 mol dm-3
KNO3: 0.20 mol dm-3 Aging temperature was kept at 90° C Aging time: 4-48 hours.
Upon completion of this aging process, the solid particles are removed from the sealed containers, and washed by resuspension in water. The magnetic properties of the colloidal particles permit their ready separation from other non-magnetic particles contained in the suspension. This separation is achieved by simply placing a magnet in contact with the side or bottom of the vessel containing the suspension, allowing the magnetic particles to collect on the interior of the vessel corresponding to the placement of the magnet and decanting the wash fluid containing the non-magnetic particles. This washing/decanting process can be repeated until essentially all non-magnetic particles and other water soluble materials are removed. The particles can thereafter be air dried or calcined. The particles obtained through this process in the foregoing manner are illustrated in Fig. 1. These particles are uniform and of a relatively narrow size distribution. The particle shape can vary from cuboidal to hexagonal, whereas relative size remains essentially uniform. In the preferred embodiments of this invention, these particles are submicron in size and most preferably in the range of from 0.1 to 0.8 micrometers. As noted above, these particles, can be calcined in the conventional manner to modify one or more of their physical properties.
These particles are unique in a number of respects (in addition to their narrow particle size distribution). The processing history and the introduction of barium ions into the ferrite crystalline lattice is believed to be responsible for attenuation of the magnetic properties of these materials, thus, accounting for reduced particle to particle interaction (aggregation). These barium modified ferrite particles are, thus, capable of formation of stable colloidal dispersions in fluid media. The surface characteristics of the particles of these colloidal dispersions have a natural affinity for adsorption of protein (i.e. cells, ligands, steroids, hormones, etc.). This adsorption is accomplished while maintaining the stability of the particle dispersion in the fluid medium.
The adsorption characteristics of the barium modified ferrites is essentially surface charge dependent. The characteristic surface charge of these particles can be readily modified by adjustment in pH. The variation in surface charge follows a characteristic signoid curve. At a pH above the particles isolectric point, the surface charge on these particles is positive; and at a pH below the isolectric point, the surface charge on these particles is negative.
Within the operational range of interest (pH 6-8), these particles can rapidly and efficiently adsorb proteinaceous materials without adverse or destructive effect upon their physical and/or physiological properties. This ability to effectively adsorb protein and its separation upon application of a magnetic field is unique to the barium modified colloidal particles of this invention. The effective adsorption of protein without disruptive effect upon the other constituents of the fluid dispersion is of critical importance not only to preservation of the adsorbed species, but also to the particulates and dissolved matter which remain within the fluid. This latter application involves the use of the colloidal particles as scavengers to remove undesirable components of a fluid sample (presumably interferents) prior to analysis of the residual material which remains in suspension. The particles, thus, have application in both industrial and biological environments, involving magnetic separation techniques of the type described in the following U.S. Patents: 4,001,288; 4,247,406; 4,018,886; 4,285,819; 4,147,767; 4,335,094; 4,152,210; 4,452,773; 4,169,804; 4,454,234; and 4,230,685 - all of which are hereby incorporated by reference in their entirety. The barium modified ferrites of this invention thus provide, for the first time, a practical and efficacious material which can perform reliably in such separation systems and yet are compatible with relatively simple, straightforward methodologies.
In a separation system of the type described in the above patents, the superparamagnetic colloidal barium ferrite particles obtained by this process can be used directly or modified by treatment with a binding material (i.e. antigen, antibody, binding protein, complement DNA), in accordance with conventional techniques described in the open literature. This treatment (coating) with these binding materials is performed under conditions which retain the desirable attributes of the barium ferrite particles. These untreated or treated particles can thereafter be combined with an industrial or biological fluid having one or more constituents capable of binding to the particles. After a suitable incubation period, the particles, and presumably the constituents of the fluid for which they are 13
specific, are then separated from the fluid utilizing conventional magnetic separation equipment and techniques. The materials separated from the fluid in this manner can either be discarded (if regarded as impurities) or recovered (if regarded as desirable constituents). In this latter instance, the particle and adsorbed constituents would simply be exposed to certain conditions (temperature and/or pH) to effect release (decoupling) of the desired constituent from the binding material. This decoupling of the adsorbed constituent allows for recycling of the ferrite particles.
The barium ferrites prepared in this manner are also suitable in other industrial and biological applications, including the use as recording media, as delivery systems for therapeutics (ceramic composition and the like).
EXAMPLES
The following materials and procedures were used in the preparation of the novel monodispersed particles of this invention. Parts and percentages appearing in such examples are by weight unless otherwise stipulated. Apparatus and techniques used in the preparation, characterization and evaluation of these particles are standard or as described hereinafter.
I. Synthesis Procedure - All chemicals were of reagent-grade quality and were used without further purification. The solutions were made up with doubly distilled water from an all-Pyrex apparatus. A stock solution of FeCl2 (1 rnol dm~3) was prepared by dissolving FeCl2*4H2θ in water under argon atmosphere to prevent air oxidation of Fe^+ ion during storage. Argon was purified from traces of carbon dioxide and oxygen by passing the gas through an alkaline pyrogallol solution.
A reactive solution is initially prepared from appropriate volumes of 5 mol dm_3 KOH and 2 mol dm_3 KNO3 stock solutions. The individual components of this reactive solution were combined in a two-necked round bottom flask, equipped with a gas -outlet and a gas-inlet. Argon was bubbled for 2 hours through a solution of desired concentrations of KOH and KNO3 in oxygen free distilled water. Subsequently, a calculated amount of a 1 mol dm"3 F Cl2 stock solution was added and bubbling of argon continued for 30 minutes. During this 30 minute period a dark green gelatinous precipitate is formed. A given volume of a 1 mol dm~3 Ba(Nθ3)2 solution was admixed to the dark-green precipitated Fe(OH)2 and bubbling of argon was continued for another 30 minutes. Equal amounts of resulting dispersion were distributed into test tubes, which were immediately tightly closed and placed in a constant temperature oven preheated to 90°C for aging. The systems were kept thermostated for 6, 24, and 48 hours. One tube was used to measure the initial pH of the suspension before aging.
The solid reaction products obtained in the foregoing manner consisted predominantly of a mixture of particles, the main fraction of which was magnetic. To separate the latter, the precipitate was first agitated in an ultrasonic bath, then the magnetic particles were retained at the bottom of the test tube with the aid of a magnet, while the remaining suspension of nonmagnetic particles was decanted. The magnetic portion was resuspended again in doubly distilled water and the washing/decanting procedure repeated several times.
II. Characterization of Physical Properties - The particles obtained by the described Synthesis Procedure above appeared either brown or black. Their shape was essentially cubic. The X-ray diffraction patterns were characteristic of barium ferrites as determined by comparisons to ASTM X-ray Data File, confirming the crystalline character of the resulting powders. Particle sizing was performed by scanning electron microscopy (of dry powders). The surface charge characterization of these particles was determined by standard electrokinetic measurements, and surface chemical composition identified by IR spectroscopy. BET gas absorption techniques were used for determination of specific surface area.
Magnetic properties were determined with a vibrating magnetometer on the original barium ferrite powders and on the annealed solids. The coercivity before annealing ranged between 60 and 100 Oe and the saturation magnetization varied between 60 and 80 emu/g, while the squareness was between 0.12 and 0.18, depending on the sample.
The particles thus obtained could be physically modified by conventional treatment regimes. For example, to anneal the particles, the calcination was carried out at temperatures ranging between 300 and 900° C for 2-12 hours in air or in an air inert atmosphere (argon). This treatment brought about some rounding of the crystal edges.
EXAMPLE I - Synthesis of Barium Containing Ferrites Having Narrow Particle Size Distribution
(A) A colloidal dispersion was prepared in accordance with the above Synthesis Procedures utilizing the following materials and under the following conditions:
FeCl2: 0.125 mol dm"3
KOH: 0.10 mol dm"3 KNO3: 0.20 mol dm-3 Ba(Nθ3)2: 0.010 mol dm"3 Initial pH: 6.7, final pH: 2.8 Temperature: 90°C
Aging time: 48 hours
The dried powders obtained by the foregoing procedures were readily redispersible in aqueous solutions. Their particle size ranged from between 0.1 and 0.8 mm (cubic edge) and the size could be altered by varying the concentrations of the solutions used in this synthesis (as illustrated in Tables I & II). As illustrated in these Tables, the chemical composition of the particles also varied with experimental conditions. Thus, the content of the barium within the ferrite could be varied between 1 to 7% by weight. As noted previously, the substitution of Ba^+ for Fe^÷ in the ferrite crystal lattice, at concentrations in the range of from about 1 to about 7% (w/w), is effective to alter the magnetic properties of these crystalline materials and, thus, substantially reduce particle to particle interaction. This modification of the classical magnetic properties of ferrites, in accordance with the process of this invention, produces submicron particles of narrow size distribution that are capable of formation of stable fluid dispersions. The following tables illustrate a series of preparations of barium modified ferrite particles. In certain instances, the relative concentrations of starting materials were varied and/or pH and/or aging times (Table I). The results of such variations are indicated in Table II. The results in Table II are specific for procedures involving an aging interval of twenty-four (24) hours.
TABLE I EXPERIMENTAL CONDITIONS
Initial cone, of sol./mol dm"3 Initial Aging
Ex. FeCl2 KOH KNO3 Ba(N03)2 pH time/hrs
II 0. 125 0.200 0.200 0.010 6.92 6,24,48
III 0.125 0.100 0.200 0.200 6.55 6,24,48
IV 0.125 0.200 0.200 0.300 6.81 6,24,48
TABLE II RESULTS AFTER 24 HOURS OF AGING
Color of pH after Test for Particles Particles
Ex. Precipitate aging B arium Shape size/micrometers
II Brown 3.41 + cubic 0.80
III Brown 3.02 + cubic 0.7-0.8
IV Black 2.22 + cubic 0.10-0.15
Note: In test for Ba, a "+" sign designates a system where barium was found in obtained precipitate. The ability to produce acceptable barium modified ferrite particles is believed attributable, in part, to the relative concentrations in starting materials, which directly effect initial pH (the operative pH range being from about 7 to about 11).
EXAMPLE V
A monoclonal antibody (MoAb) specific for a surface marker on human red blood cells, is directly adsorbed onto the colloidal barium ferrite particles of Example I. The particle size of the ferrite particle selected for use in the system was approximately 1.09 micrometers. Sufficient MoAb was contacted with the colloidal particles to effect essentially complete saturations of the particle surface.
Antibody coated barium ferrite particles were then slurried with a whole blood sample for a brief incubation period, a magnet placed in contact with the bottom of the container and magnetic particles allowed to collect upon the inside surface of the container opposite the magnet. After a relative brief interval, the fluid phase of the sample is substantially depleted of both red blood cells and magnetic particles. The fluid phase is then aspirated from the sample container into a Coulter Model S-Plus cell counter and the sample subjected to analysis. The data available from such analysis permitted the identification of two discrete sub-populations of white blood cells. The ability to effectively separate erythrocytes from a whole blood sample in the above manner, without the resort to lytic reagents, offers significant advantages in the recovery of the leukocyte population. More specifically, the magnetic separation which is effected in the above manner has been achieved without substantial alteration in the physiological environment of the sample. Thus, the leukocytes have retained their native physical, chemical and immunochemical properties. This can be critical in further differentiation of the leukocyte sub-populations from one another and in the continued vitality of these cells.

Claims

WHAT IS CLAIMED IS:
1. In a process for the preparation of colloidal particles of barium ferrites by phase transformation of a gel at elevated temperatures, the improvement comprising:
(a) forming a gelatinous dispersion from an aqueous solution of a ferrous salt, potassium hydroxide and potassium nitrate under non-oxidizing conditions;
(b) contacting said gelatinous dispersion with an aqueous solution of a barium salt under non-oxidizing conditions; and
(c) aging the dispersion/solution at elevated temperatures for an interval sufficient to effect a phase transformation of the gelatinous dispersion to crystalline solids having barium incorporated within a ferrite crystal lattice.
2. The improved process of claim 1, wherein the barium salt is a barium nitrate.
3. The improved process of claim 1, wherein the aging of the gelatinous solids is performed at a temperature in the range of from about 80 to about 90° C for a period sufficient to effect essentially complete transformation of a barium ferrite gel to the barium ferrite solid.
4. The improved process of claim 3, wherein the aging of gelatinous solids is performed in a sealed container.
5. A composition comprising monodispersed particles having ferrite crystalline lattice, from about 1 to about 7 weight percent barium ions within said lattice, a particle size in the range from about 0.1 to about 1.0 micrometers superparamagnetic response to a magnetic field, a coercivity in the range of from about 60 and 100 Oe, essentially cuboidal in shape and capable of formation of a stable colloidal dispersion in aqueous medium.
PCT/US1988/000083 1987-01-16 1988-01-14 Process for preparation of monodispersed barium containing ferrites WO1988005337A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO884064A NO884064L (en) 1987-01-16 1988-09-13 PROCEDURE FOR THE PREPARATION OF MONODISPERGED BARIUM-CONTAINED FERRITES.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US389987A 1987-01-16 1987-01-16
US003,899 1987-01-16

Publications (1)

Publication Number Publication Date
WO1988005337A1 true WO1988005337A1 (en) 1988-07-28

Family

ID=21708130

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1988/000083 WO1988005337A1 (en) 1987-01-16 1988-01-14 Process for preparation of monodispersed barium containing ferrites

Country Status (4)

Country Link
EP (1) EP0302912A4 (en)
JP (1) JPH01503623A (en)
AU (1) AU1222988A (en)
WO (1) WO1988005337A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5062991A (en) * 1990-06-04 1991-11-05 Coulter Corporation In situ use of gelatin in the preparation of uniform ferrite particles
US5240640A (en) * 1990-06-04 1993-08-31 Coulter Corporation In situ use of gelatin or an aminodextran in the preparation of uniform ferrite particles
DE4325071A1 (en) * 1993-07-19 1995-01-26 Lancaster Group Ag Preparation for circulation promotion
EP2277544A1 (en) * 2009-07-08 2011-01-26 Nelica Ciobanu Biocompatible magnetic nano-clusters containing iron oxide respectively iron oxide - boron with primary use in magnetic drug targeting and boron neutron capture therapy
CN103801241A (en) * 2014-02-27 2014-05-21 东华大学 Method for preparing developing photonic crystal microspheres by using micro-reaction device and applied magnetic field
US10569250B2 (en) * 2015-12-07 2020-02-25 Research Center For Eco-Environmental Sciences, Chinese Academy Of Sciences Magnetic adsorbent for removing arsenic and antimony by means of adsorption-superconducting magnetic separation and preparation method therefor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634254A (en) * 1969-06-16 1972-01-11 Gen Motors Corp Method of coprecipitating hexagonal ferrites
US4529524A (en) * 1983-12-26 1985-07-16 Toda Kogyo Corp. Process for producing plate-like barium ferrite particles for magnetic recording

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634254A (en) * 1969-06-16 1972-01-11 Gen Motors Corp Method of coprecipitating hexagonal ferrites
US4529524A (en) * 1983-12-26 1985-07-16 Toda Kogyo Corp. Process for producing plate-like barium ferrite particles for magnetic recording

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP0302912A4 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5062991A (en) * 1990-06-04 1991-11-05 Coulter Corporation In situ use of gelatin in the preparation of uniform ferrite particles
EP0532684A1 (en) * 1990-06-04 1993-03-24 Coulter Corp In situ use of gelatin in the preparation of uniform ferrite particles.
EP0532684A4 (en) * 1990-06-04 1993-08-18 Coulter Corporation In situ use of gelatin in the preparation of uniform ferrite particles
US5240640A (en) * 1990-06-04 1993-08-31 Coulter Corporation In situ use of gelatin or an aminodextran in the preparation of uniform ferrite particles
AU654285B2 (en) * 1990-06-04 1994-11-03 Coulter Corporation In situ use of gelatin in the preparation of uniform ferrite particles
DE4325071A1 (en) * 1993-07-19 1995-01-26 Lancaster Group Ag Preparation for circulation promotion
EP2277544A1 (en) * 2009-07-08 2011-01-26 Nelica Ciobanu Biocompatible magnetic nano-clusters containing iron oxide respectively iron oxide - boron with primary use in magnetic drug targeting and boron neutron capture therapy
CN103801241A (en) * 2014-02-27 2014-05-21 东华大学 Method for preparing developing photonic crystal microspheres by using micro-reaction device and applied magnetic field
CN103801241B (en) * 2014-02-27 2015-12-02 东华大学 Micro-reaction device and externally-applied magnetic field is utilized to prepare the method for colour developing photon crystal micro-ball
US10569250B2 (en) * 2015-12-07 2020-02-25 Research Center For Eco-Environmental Sciences, Chinese Academy Of Sciences Magnetic adsorbent for removing arsenic and antimony by means of adsorption-superconducting magnetic separation and preparation method therefor

Also Published As

Publication number Publication date
EP0302912A4 (en) 1990-04-10
JPH01503623A (en) 1989-12-07
EP0302912A1 (en) 1989-02-15
AU1222988A (en) 1988-08-10

Similar Documents

Publication Publication Date Title
JP2757964B2 (en) Magnetic attractive particles and method for producing the same
Matijevic Uniform inorganic colloid dispersions. Achievements and challenges
Li et al. Preparation of core‐shell magnetic molecularly imprinted polymer nanoparticles for recognition of bovine hemoglobin
Meldrum et al. Magnetoferritin: in vitro synthesis of a novel magnetic protein
US4834898A (en) Reagents for magnetizing nonmagnetic materials
Jolivet et al. Synthesis of iron oxide-based magnetic nanomaterials and composites
Roy et al. Soft template induced phase selective synthesis of Fe 2 O 3 nanomagnets: one step towards peroxidase-mimic activity allowing colorimetric sensing of thioglycolic acid
JPS6056537B2 (en) Magnetic beneficiation method
WO2008136853A2 (en) Methods for separating magnetic nanoparticles
EP1376129B1 (en) Magnetic carrier for biological substance, production method thereof and isolation method of biological substance using the same
GB1597680A (en) Manufacture of acicular ferromagnetic pigment particles
WO1988005337A1 (en) Process for preparation of monodispersed barium containing ferrites
US4225426A (en) Magnetic beneficiation of clays utilizing magnetic particulates
CN105435753A (en) A mesoporous magnetic polymer composite sphere, a preparing method thereof and applications of the composite sphere
US4219408A (en) Magnetic separation of minerals utilizing magnetic particulates
CN1232553C (en) Ferromagnetic microsphere medium made from urea-formaldehyde resin and its preparation method
Matijevic Colloid chemical aspects of corrosion of metals
CN108109805B (en) Carboxylic acid type magnetic nano particle prepared by PEG regulation and control and application thereof
JP4080798B2 (en) Magnetic carrier for binding nucleic acid and method for producing the same
US3905841A (en) Method of improving dispersability of small metallic magnetic particles in organic resin binders
CN110614082B (en) Carbon black-superparamagnetic Fe3O4Preparation and application of nano-composite
JP2006104021A (en) Composite particle
JP3119362B2 (en) Method for producing cobalt-modified acicular iron oxide
JPH03237019A (en) Ferrite coating method
JPH0692640A (en) Fine magnetic particle for marking biological material and its production

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR JP NO

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1988901364

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1988901364

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1988901364

Country of ref document: EP